Zobrazeno 1 - 10
of 175
pro vyhledávání: '"Reynolds M Delgado"'
Autor:
Vishal Parikh, O.H. Frazier, Angel Moctezuma-Ramirez, Harveen K. Lamba, Reynolds M. Delgado, Joggy George, Ajith Nair, Umang M. Parikh, Savitri Fedson
Publikováno v:
General Thoracic and Cardiovascular Surgery. 68:1278-1284
Warfarin is standard anticoagulation therapy for patients with a continuous-flow left ventricular assist device (CF-LVAD). However, warfarin requires regular monitoring and dosage adjustments and fails for many patients, causing thromboembolic and bl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaeb75f84cdc15bb210b0bac409c8f08
https://doi.org/10.1007/s11748-020-01371-w
https://doi.org/10.1007/s11748-020-01371-w
Autor:
Reynolds M Delgado, O H Frazier, Faisal H. Cheema, Andrew D Lee, Fadi I Musfee, George V. Letsou
Publikováno v:
Tex Heart Inst J
We report the long-term survival of a 46-year-old man supported with a HeartMate II continuous-flow left ventricular assist device after complex repair of a bicuspid aortic valve, anomalous left main coronary artery, and dilated aorta. He has been ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47abb1b1a91a3760d81862df0a81d808
https://doi.org/10.14503/thij-19-7193
https://doi.org/10.14503/thij-19-7193
Autor:
Ziad Taimeh, Jeffrey A. Morgan, Leo Simpson, Andrew B. Civitello, Harveen K. Lamba, Ajith Nair, Brendan Chou, Faisal H. Cheema, Reynolds M. Delgado, O.H. Frazier, Todd K. Rosengart, S. Oberton
Publikováno v:
ASAIO Journal. 66:64-68
Implantable continuous-flow left ventricular assist devices (CF-LVADs) are used for long-term LV support in bridging patients to heart transplantation or as destination therapy. With prolonged support times, some patients will have repeat complicatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a24e9a9a15a1e9a11fad517894af471
https://doi.org/10.1097/mat.0000000000000928
https://doi.org/10.1097/mat.0000000000000928
Autor:
Gregory Long, Andrew B. Civitello, Brendan Chou, Harveen K. Lamba, Andre C. Critsinelis, Reynolds M. Delgado, Subhasis Chatterjee
Publikováno v:
Tex Heart Inst J
To determine whether the cause of cardiomyopathy affects outcomes in patients who undergo continuous-flow left ventricular assist device support, we compared postimplant adverse events and survival between patients with ischemic and nonischemic cardi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d552feb2443f350201e712e88a549a5
https://pubmed.ncbi.nlm.nih.gov/34468765
https://pubmed.ncbi.nlm.nih.gov/34468765
Autor:
Masashi Kawabori, Andre C. Critsinelis, Reynolds M. Delgado, Ajith Nair, O.H. Frazier, Joggy George, Chitaru Kurihara, Tadahisa Sugiura, Jeffrey A. Morgan, Leo Simpson, Azeen Anjum, Whitson B. Etheridge, Andrew B. Civitello
Publikováno v:
Journal of Artificial Organs. 21:285-292
Continuous-flow left ventricular assist devices (CF-LVADs) are increasingly being used to treat advanced, refractory chronic heart failure. Herein, we sought to determine the incidence of postoperative acute kidney injury (AKI) in axial-flow (HeartMa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::203d01c74e387b720f9389ef6ede69f9
https://doi.org/10.1007/s10047-018-1047-0
https://doi.org/10.1007/s10047-018-1047-0
Plasmapheresis in Patients With Heparin-induced Thrombocytopenia Requiring Ventricular Assist Device
Autor:
Andrew B. Civitello, Jeffrey A. Morgan, Harveen K. Lamba, Leo Simpson, Cassius Kwasi Mensah, Salvador R. Maffei, Arthur W. Bracey, Ajith Nair, O.H. Frazier, Reynolds M. Delgado
Publikováno v:
The Annals of Thoracic Surgery. 109:e439-e440
Anticoagulation with unfractionated heparin is vital to reduce the risk of thromboembolic events during cardiopulmonary bypass and left ventricular assist device placement. However patients with heparin-induced thrombocytopenia are at risk of develop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4cf61dcd84e18f0573cc3ef8e70f63e7
https://doi.org/10.1016/j.athoracsur.2019.09.056
https://doi.org/10.1016/j.athoracsur.2019.09.056
Autor:
Todd K. Rosengart, Michelle Tu Anh Nguyen, Faisal H. Cheema, Jeffrey A. Morgan, O.H. Frazier, Ajith Nair, Andrew B. Civitello, Andre C. Critsinelis, Subhasis Chatterjee, S. Oberton, Harveen K. Lamba, Reynolds M. Delgado, Jacob R Conroy
Publikováno v:
ASAIO journal (American Society for Artificial Internal Organs : 1992). 66(5)
In this study, we sought to determine the accuracy of several critical care risk scores for predicting survival of Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) Profile 1 patients after continuous-flow left ventricula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::183eecd67dd2eb0751245bc05073140f
https://pubmed.ncbi.nlm.nih.gov/31335367
https://pubmed.ncbi.nlm.nih.gov/31335367
Autor:
Andrew B. Civitello, O.H. Frazier, Mary Kim, Harveen K. Lamba, Todd K. Rosengart, S. Oberton, Brendan Chou, Ajith Nair, Ziad Taimeh, Reynolds M. Delgado, Jeffrey A. Morgan, Leo Simpson
Publikováno v:
Stroke. 50
Introduction: Postoperative atrial fibrillation (POAF) is one of the most common complications after cardiac surgery and is especially hazardous in elderly patients and those with left ventricular dysfunction. Therefore, we sought to find the associa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::204aaf4842aafbea94a3abfa0e5dad3b
https://doi.org/10.1161/str.50.suppl_1.tp211
https://doi.org/10.1161/str.50.suppl_1.tp211
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S388
Purpose Left ventricular assist devices (LVAD) are standard of care for management of end-stage heart failure. LVAD patients are on antiplatelet agents and long-term anticoagulation with warfarin to prevent thrombotic events. The ease of use, superio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb8de08aa6b3e520010c64742cdae566
https://doi.org/10.1016/j.healun.2021.01.1091
https://doi.org/10.1016/j.healun.2021.01.1091
Autor:
Andrew B. Civitello, Gabriel Loor, Reynolds M. Delgado, Ajith Nair, Alexis E. Shafii, Salman Bandeali, Leslie Ammabel Ynalvez, Joggy George, S. Oberton, Jeffrey A. Morgan, Leo Simpson, Hong Loan Nguyen, Kenneth Liao, Samar Seth, Deepthi Sudhakar, Ziad Taimeh
Publikováno v:
Journal of Cardiac Failure. 25:S188-S189
Introduction Patients with refractory cardiogenic shock have a mortality in excess of 80%. The use of percutaneous mechanical circulatory support devices to bridge patients with refractory cardiogenic shock to definitive therapy has steadily increase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b670cfca5c06610d2708a2fa63f17566
https://doi.org/10.1016/j.cardfail.2019.07.530
https://doi.org/10.1016/j.cardfail.2019.07.530